Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT).
A conjugated bile acid, 23-selena-25-homotaurocholic acid (SeHCAT), labeled with the gamma emitter Se-75, has been evaluated in man. Absorption and excretion were compared with that of simultaneously administered [23-14C]cholic acid. SeHCAT is absorbed quantitatively following oral administration, secreted into the bile at the same rate as cholic acid, reabsorbed from the small intestine, and resecreted. It is not absorbed when the terminal ileum has been excised or bypassed. SeHCAT is therefore the first of a new class of radiopharmaceuticals, namely, gamma-emitting tracers of the complete cycle of the enterohepatic circulation. Its use will simplify investigation of the functional state of the terminal ileum by eliminating the need to collect and process feces.
D000284:Administration, Oral; D000818:Animals; D001646:Bile / Q000378:metabolism; D001660:Biliary Tract Diseases / Q000000981:diagnostic imaging / Q000503:physiopathology; D001822:Body Burden; D002793:Cholic Acids / Q000008:administration & dosage / Q000502:physiology; D004341:Drug Evaluation; D004764:Enterohepatic Circulation; D005704:Gallbladder / Q000098:blood supply / Q000000981:diagnostic imaging; D006801:Humans; D007082:Ileum / Q000098:blood supply / Q000000981:diagnostic imaging* / Q000502:physiology; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D008099:Liver / Q000098:blood supply / Q000000981:diagnostic imaging; D011868:Radioisotopes; D011877:Radionuclide Imaging; D051381:Rats; D013656:Taurocholic Acid / Q000031:analogs & derivatives*
D002793:Cholic Acids; D011868:Radioisotopes; D013656:Taurocholic Acid; C033638:23-seleno-25-homotaurocholic acid